P53/NANOG balance; the leading switch between poorly to well differentiated status in liver cancer cells
Authors/Creators
- 1. Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran
- 2. Experimental Cancer Medicine, Institution for Laboratory Medicine, Karolinska Institute and Karolinska University Hospital-Huddinge, Huddinge, Sweden
- 3. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, Iran
-
4.
Karolinska Institutet
- 5. Karolinska Universitetsjukhuset i Huddinge
-
6.
Royan Institute
Description
The review discusses the role of the p53/NANOG balance in determining the differentiation status of liver cancer cells. Activation of the tumor suppressor p53 is identified as an important factor in apoptosis induction and maintenance of a well-differentiated cellular state, whereas higher NANOG expression is associated with poorly differentiated status. Inducing NANOG expression while reducing p53 levels can switch liver cancer cells from a well-differentiated to a poorly differentiated state. The review highlights the cross-talk between p53 and NANOG in hepatocellular carcinoma (HCC), regulated through mitophagy, and presents this pathway as a potential molecular target for attenuating the cancerous phenotype and managing HCC.
Files
P53:NANOG balance; the leading switch between poorly to well differentiated status in liver cancer cells.pdf
Additional details
Identifiers
Related works
- Is published in
- Journal article: 10.3389/fonc.2024.1377761 (DOI)
Dates
- Accepted
-
2024-05-23
References
- Ranjbar-Niavol F, Rezaei N, Zhao Y, Mirzaei H, Hassan M, Vosough M. P53/NANOG balance; the leading switch between poorly to well differentiated status in liver cancer cells. Frontiers in Oncology. 2024;14:1377761. Published 23 May 2024. doi:10.3389/fonc.2024.1377761.